by The global intravenous immunoglobulin market size was approximate at US$ 13.69 billion in 2022 and is anticipated to grow US$ 29.53 billion by 2032, registering a compound annual growth rate of 7.99% from 2023 to 2032.
The intravenous immunoglobulin market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the intravenous immunoglobulin market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the intravenous immunoglobulin report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the intravenous immunoglobulin market have been studied and analysed across many developments.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2996
Intravenous Immunoglobulin Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 14.78 Billion |
| Market Size by 2032 | USD 29.53 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 7.99% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Route of Administration, By Application, By End-Users, and By Distribution Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: High Barrier Packaging Films Market Size to Grow US$ 27.11 Billion By 2032
Research Approach
The comprehensive report on the global intravenous immunoglobulin market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global intravenous immunoglobulin market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- Biotest AG
- Octapharma AG
- LFB Biotechnologies
- Grifols SA
- CSL Behring
- China Biologics Products Inc.
- Kedrion Biopharma
- BDI Pharma Inc.
Intravenous Immunoglobulin Market Segmentations
By Product
- IGG
- IGA
- IGM
- IGE
- IGD
By Route of Administration
- Intravenous
- Subcutaneous
By Application
- Hypogammaglobulinemia
- Chronic Inflammatory demyelinating polyneuropathy (CIDP)
- Immunodeficiency diseases
- Myasthenia Gravis
- Multifocal motor neuropathy
- Idiopathic thrombocytopenic purpura (ITP)
- Inflammatory myopathies
- Specific antibody deficiency
- Guillain-Barre syndrome
By End-Users
- Hospitals
- Homecare
- Specialty Clinics
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacies
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Intravenous Immunoglobulin Market
5.1. COVID-19 Landscape: Intravenous Immunoglobulin Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Intravenous Immunoglobulin Market, By Product
8.1. Intravenous Immunoglobulin Market Revenue and Volume, by Product, 2023-2032
8.1.1. IGG
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. IGA
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. IGM
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. IGE
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
8.1.5. IGD
8.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Intravenous Immunoglobulin Market, By Route of Administration
9.1. Intravenous Immunoglobulin Market Revenue and Volume, by Route of Administration, 2023-2032
9.1.1. Intravenous
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Subcutaneous
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Intravenous Immunoglobulin Market, By Application
10.1. Intravenous Immunoglobulin Market Revenue and Volume, by Application, 2023-2032
10.1.1. Hypogammaglobulinemia
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Immunodeficiency diseases
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Myasthenia Gravis
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Multifocal motor neuropathy
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
10.1.6. Idiopathic thrombocytopenic purpura (ITP)
10.1.6.1. Market Revenue and Volume Forecast (2020-2032)
10.1.7. Inflammatory myopathies
10.1.7.1. Market Revenue and Volume Forecast (2020-2032)
10.1.8. Specific antibody deficiency
10.1.8.1. Market Revenue and Volume Forecast (2020-2032)
10.1.9. Guillain-Barre syndrome
10.1.9.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Intravenous Immunoglobulin Market, By End-Users
11.1. Intravenous Immunoglobulin Market Revenue and Volume, by End-Users, 2023-2032
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Homecare
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Specialty Clinics
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Intravenous Immunoglobulin Market, By Distribution Channel
12.1. Intravenous Immunoglobulin Market Revenue and Volume, by Distribution Channel, 2023-2032
12.1.1. Hospital Pharmacy
12.1.1.1. Market Revenue and Volume Forecast (2020-2032)
12.1.2. Retail Pharmacy
12.1.2.1. Market Revenue and Volume Forecast (2020-2032)
12.1.3. Online Pharmacies
12.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 13. Global Intravenous Immunoglobulin Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.1.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.6.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.7.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.1.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.1.7.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.2.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.7. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.2.8. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.2.9.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.10. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.2.11. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.2.12.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.12.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.2.13. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.2.14.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.2.14.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.2.15. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.3.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.6.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.3.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.8.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.3.9. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.3.10.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.10.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.3.11.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.3.11.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.4.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.6.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.4.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.8.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.4.9. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.4.10.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.10.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.4.11.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.4.11.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.5.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.6.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.5.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
13.5.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
13.5.8.4. Market Revenue and Volume Forecast, by End-Users (2020-2032)
13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)
Chapter 14. Company Profiles
14.1. Biotest AG
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Octapharma AG
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. LFB Biotechnologies
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Grifols SA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. CSL Behring
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. China Biologics Products Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kedrion Biopharma
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. BDI Pharma Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global intravenous immunoglobulin market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for intravenous immunoglobulin are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
